
Timothy Gale Rodgers MD
Dermatologic Surgery, Dermatopathology, Pediatric Dermatology
Rodgers Dermatology
Join to view full profile
3880 Parkwood BlvdSuite 102Frisco, TX 75034
Phone+1 972-704-2400
Fax+1 972-704-2255
Dr. Rodgers is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Timothy Rodgers is a dermatologist in Frisco, TX in private practice. He received his medical degree from Northwestern University and completed his dermatology residency at the University of Michigan. He has been in practice since 2006. He is experienced in non-melanoma skin cancer, Mohs micrographic surgery, melanoma and cutaneous malignancies, laser dermatologic surgery, and complex medical dermatology.
Education & Training
University of MichiganResidency, Dermatology, 2003 - 2006
McGaw Medical Center of Northwestern UniversityInternship, Internal Medicine, 2002 - 2003
Northwestern University The Feinberg School of MedicineClass of 2002
Certifications & Licensure
TX State Medical License 2005 - 2026
MI State Medical License 2003 - 2006
IL State Medical License 2002 - 2003
American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EMA, Modernizing Medicine, Inc., 2015-2017
- CMS Meaningful Use Stage 2 Certification EMA, Modernizing Medicine, Inc., 2015-2017
- CMS Meaningful Use Stage 2 Certification EMA Mobile, Modernizing Medicine, Inc., 2015-2017
Clinical Trials
- A Study of LY3471851 in Participants With Eczema Start of enrollment: 2019 Dec 04
- A Study of LY3471851 in Participants With Psoriasis Start of enrollment: 2019 Nov 26
- A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period Start of enrollment: 2023 Nov 06
Roles: Principal Investigator
Publications & Presentations
PubMed
- 30 citationsDrug-associated histiocytoid Sweet's syndrome: a true neutrophilic maturation arrest variant.Angela J. Wu, Timothy Rodgers, Douglas R. Fullen
Journal of Cutaneous Pathology. 2007-08-15
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









